Home/Filings/4/0001193125-26-006288
4//SEC Filing

Cohen Fred E 4

Accession 0001193125-26-006288

CIK 0001652130other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:05 PM ET

Size

5.1 KB

Accession

0001193125-26-006288

Insider Transaction Report

Form 4
Period: 2026-01-05
Cohen Fred E
Director
Transactions
  • Purchase

    Common Stock

    2026-01-05$9.35/sh+150,000$1,402,500207,453 total
Footnotes (2)
  • [F1]Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price.

Documents

1 file

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001339358

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:05 PM ET
Size
5.1 KB